-
EP4000603
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4000603
| EP4000603 - COMPOSITION FOR INHIBITING SAPONIN-INDUCED HEMOLYSIS, CONTAINING CATIONIC LIPOSOME [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 22.04.2022 Database last updated on 10.08.2024 | |
| Former | The international publication has been made Status updated on 07.01.2022 | Most recent event Tooltip | 23.03.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Eyegene, Inc. B-910 401, Yangcheon-ro Gangseo-gu Seoul 07528 / KR | [2022/21] | Inventor(s) | 01 /
CHO, Yang Je Seoul 04423 / KR | 02 /
LEE, Na Gyong Seoul 01913 / KR | 03 /
KIM, Kwangsung Goyang-si Gyeonggi-do 10371 / KR | 04 /
PARK, Shin Ae Ganghwa-gun Incheon 23048 / KR | 05 /
AHN, Sunyoung Goyang-si Gyeonggi-do 10550 / KR | [2022/21] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [2022/21] | Application number, filing date | 21832972.0 | 28.05.2021 | [2022/21] | WO2021IB54673 | Priority number, date | KR20200080178 | 30.06.2020 Original published format: KR 20200080178 | [2022/21] | Filing language | KO | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022003443 | Date: | 06.01.2022 | Language: | KO | [2022/01] | Type: | A1 Application with search report | No.: | EP4000603 | Date: | 25.05.2022 | Language: | EN | [2022/21] | Search report(s) | International search report - published on: | KR | 06.01.2022 | (Supplementary) European search report - dispatched on: | EP | 10.07.2023 | Classification | IPC: | A61K9/127, A61K31/704, A61K36/185, A61K47/69, A61P37/00, A61K31/7048 | [2023/32] | CPC: |
A61K9/1272 (EP,US);
A61K9/1271 (KR);
A61K31/704 (EP,KR,US);
A61K31/7048 (EP);
A61K36/185 (KR);
A61K47/6911 (EP,KR);
|
| Former IPC [2022/21] | A61K9/127, A61K31/704, A61K36/185, A61K47/69, A61P37/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/21] | Title | German: | ZUSAMMENSETZUNG ZUR HEMMUNG DER SAPONIN-INDUZIERTEN HÄMOLYSE MIT EINEM KATIONISCHEN LIPOSOM | [2022/21] | English: | COMPOSITION FOR INHIBITING SAPONIN-INDUCED HEMOLYSIS, CONTAINING CATIONIC LIPOSOME | [2022/21] | French: | COMPOSITION D'INHIBITION DE L'HÉMOLYSE INDUITE PAR LA SAPONINE, CONTENANT UN LIPOSOME CATIONIQUE | [2022/21] | Entry into regional phase | 17.02.2022 | Translation filed | 17.02.2022 | National basic fee paid | 17.02.2022 | Search fee paid | 17.02.2022 | Designation fee(s) paid | 17.02.2022 | Examination fee paid | Examination procedure | 17.02.2022 | Examination requested [2022/21] | 06.02.2024 | Amendment by applicant (claims and/or description) | 06.02.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 24.03.2023 | Renewal fee patent year 03 | 22.03.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]KR20190021938 (EYEGENE INC [KR]) [X] 1-14 * paragraph [0014] * * paragraph [0019] - paragraph [0020] * * paragraph [0020] * * paragraph [0027] - paragraph [0028] * * paragraph [0084] * * paragraph [0131] - paragraph [0132] * * paragraph [0167] - paragraph [0168] * * paragraph [0258] - paragraph [0259] *; | [X] - CHIA-LING CHAN ET AL, "Optimizing cationic and neutral lipids for efficient gene delivery at high serum content", THE JOURNAL OF GENE MEDICINE, (20140401), doi:10.1002/jgm.2762, ISSN 1099-498X, pages n/a - n/a, XP055116908 [X] 11-14 * page 5, paragraph 2 - page 6 * DOI: http://dx.doi.org/10.1002/jgm.2762 | [A] - SELYUTINA O YU ET AL, "Effect of glycyrrhizic acid on hemolysis of red blood cells and properties of cell membranes", RUSSIAN CHEMICAL BULLETIN, SPRINGER US, NEW YORK, vol. 63, no. 5, doi:10.1007/S11172-014-0573-Z, ISSN 1066-5285, (20150228), pages 1201 - 1204, (20150228), XP035459632 [A] 1-14 * the whole document * DOI: http://dx.doi.org/10.1007/s11172-014-0573-z | International search | [A]KR20070114854 (GLAXOSMITHKLINE BIOLOG SA [BE]) [A] 1-14 * See claims 1-20. *; | [A]JP2014503475 (AC IMMUNE S.A.) [A] 1-14* See entire document. *; | [A]KR20170007242 (THE GOVERNMENT OF THE US SECRETARY OF THE ARMY [US]) [A] 1-14 * See claims 1-3 and 18. *; | [XA]KR20190021938 (EYEGENE INC [KR]) [X] 11-14 * See claims 1, 3-5 and 11; and paragraphs [0002] and [0146]. * [A] 1-10; | [X]JP2020502258 (EYEGENE INC.) [X] 11-14 * See claims 1, 3 and 4; and paragraph [0002]. * | by applicant | - NEWMAN MJ et al., J. Immunol., (19920000), vol. 148, pages 2357 - 2362 | - SUN HX et al., Vaccine, (20090000), vol. 27, pages 1787 - 1796 | - KWANG JAE CHO, Korean Journal of Otorhinolaryngology-Head and Neck Surgery, (20070000), vol. 50, no. 7, pages 562 - 572 | - Remington's Pharmaceutical Science, Mack Publishing Co. |